NirvanamKnowledge · Cases · Solver

Drug Class

PCSK9 Inhibitors

AMD:CLASS:00876

Agents that inhibit Proprotein Convertase Subtilisin/Kexin Type 9 (see PROPROTEIN CONVERTASE 9 (PCSK9)), an enzyme that plays an important role in the degradation of the LDL receptors. It favors LDL catabolism and reduces plasma LDL-cholesterol (LDL_C) level.

Pharmacology management
Read knowledge page ↗ Open graph Embed card

Graph assertions

PCSK9 Inhibitors has parent drug class Anticholesteremic Agents
PCSK9 Inhibitors has parent drug class Serine Proteinase Inhibitors

Embed this node